T. Rowe Price Associates
NPSP

T. Rowe Price Associates’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

T. Rowe Price Associates’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-478,065
Closed -$17.1M – 2605
2014
Q4 		$17.1M Sell
478,065
-19,135
-4% -$571K ﹤0.01% 1166
2014
Q3 		$12.9M Buy
497,200
+5,900
+1% +$169K ﹤0.01% 1242
2014
Q2 		$16.2M Buy
491,300
+23,900
+5% +$690K ﹤0.01% 1176
2014
Q1 		$14M Buy
467,400
+11,200
+2% +$386K ﹤0.01% 1212
2013
Q4 		$13.8M Buy
456,200
+221,000
+94% +$6.09M ﹤0.01% 1199
2013
Q3 		$7.48M Buy
235,200
+46,600
+25% +$1.07M ﹤0.01% 1339
2013
Q2 		$2.85M Buy
+188,600
New +$2.61M ﹤0.01% 1483

Other funds holding NPSP

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

T. Rowe Price Associates's NPSP Position: Q1 2015 in Review

T. Rowe Price Associates sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 478,065 shares — an estimated $17.1M sold.

T. Rowe Price Associates first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $17.1M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • T. Rowe Price Associates reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 478,065 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $17.1M.
  • T. Rowe Price Associates first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • T. Rowe Price Associates's NPS PHARMACEUTICALS INC position peaked at $17.1M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.